BIOMAT Database Logo BIOMAT Database Logo

The selectivity of statine-based inhibitors against various human aspartic proteinases. 1990

R A Jupp, and B M Dunn, and J W Jacobs, and G Vlasuk, and K E Arcuri, and D F Veber, and D S Perlow, and L S Payne, and J Boger, and S de Laszlo
Department of Biochemistry, University of Wales College of Cardiff, U.K.

The interactions of five human enzymes (renin, pepsin, gastricsin, cathepsin D and cathepsin E) and the aspartic proteinase from Endothia parasitica with several series of synthetic inhibitors were examined. All of the inhibitors contained the dipeptide analogue statine or its phenylalanine or cyclohexylalanine homologues in the P1-P1' positions. The residues occupying the peripheral sub-sites (P4 to P3') were varied systematically and inhibitory constants were determined for the interactions with each of the proteinases. Inhibitors were elucidated that specifically inhibited human renin and did not affect any of the other human enzymes or the fungal proteinase. With suitable selection of residues to occupy individual sub-sites, effective inhibitors of specific human aspartic proteinases may now be designed.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D016282 Aspartic Acid Endopeptidases A sub-subclass of endopeptidases that depend on an ASPARTIC ACID residue for their activity. Aspartic Endopeptidases,Aspartyl Endopeptidases,Acid Endopeptidases, Aspartic,Endopeptidases, Aspartic Acid,Endopeptidases, Aspartyl
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

R A Jupp, and B M Dunn, and J W Jacobs, and G Vlasuk, and K E Arcuri, and D F Veber, and D S Perlow, and L S Payne, and J Boger, and S de Laszlo
Aspartic proteinases and their inhibitors.
December 1985, Biochemical Society transactions,
R A Jupp, and B M Dunn, and J W Jacobs, and G Vlasuk, and K E Arcuri, and D F Veber, and D S Perlow, and L S Payne, and J Boger, and S de Laszlo
Inhibition of aspartic proteinases by peptides containing lysine and ornithine side-chain analogues of statine.
February 1987, Journal of medicinal chemistry,
R A Jupp, and B M Dunn, and J W Jacobs, and G Vlasuk, and K E Arcuri, and D F Veber, and D S Perlow, and L S Payne, and J Boger, and S de Laszlo
Substrate specificity and inhibitors of aspartic proteinases.
January 1992, Scandinavian journal of clinical and laboratory investigation. Supplementum,
R A Jupp, and B M Dunn, and J W Jacobs, and G Vlasuk, and K E Arcuri, and D F Veber, and D S Perlow, and L S Payne, and J Boger, and S de Laszlo
Aspartic proteinases and inhibitors in plant pathogenesis.
January 1998, Advances in experimental medicine and biology,
R A Jupp, and B M Dunn, and J W Jacobs, and G Vlasuk, and K E Arcuri, and D F Veber, and D S Perlow, and L S Payne, and J Boger, and S de Laszlo
Expression of chimeric human aspartic proteinases.
January 1998, Advances in experimental medicine and biology,
R A Jupp, and B M Dunn, and J W Jacobs, and G Vlasuk, and K E Arcuri, and D F Veber, and D S Perlow, and L S Payne, and J Boger, and S de Laszlo
Genetic variation of human aspartic proteinases.
January 1992, Scandinavian journal of clinical and laboratory investigation. Supplementum,
R A Jupp, and B M Dunn, and J W Jacobs, and G Vlasuk, and K E Arcuri, and D F Veber, and D S Perlow, and L S Payne, and J Boger, and S de Laszlo
Development and testing of inhibitors of Candida aspartic proteinases.
January 1998, Advances in experimental medicine and biology,
R A Jupp, and B M Dunn, and J W Jacobs, and G Vlasuk, and K E Arcuri, and D F Veber, and D S Perlow, and L S Payne, and J Boger, and S de Laszlo
Macrocyclic statine-based inhibitors of BACE-1.
November 2007, Chembiochem : a European journal of chemical biology,
R A Jupp, and B M Dunn, and J W Jacobs, and G Vlasuk, and K E Arcuri, and D F Veber, and D S Perlow, and L S Payne, and J Boger, and S de Laszlo
Structure-based subsite specificity mapping of human cathepsin D using statine-based inhibitors.
July 1997, Protein science : a publication of the Protein Society,
R A Jupp, and B M Dunn, and J W Jacobs, and G Vlasuk, and K E Arcuri, and D F Veber, and D S Perlow, and L S Payne, and J Boger, and S de Laszlo
Bacterial aspartic proteinases.
June 1997, FEBS letters,
Copied contents to your clipboard!